查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945353

2026年全球植入式輸液幫浦市場報告

Implantable Infusion Pumps Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入式輸液幫浦市場經歷了顯著成長，預計將從2025年的203.2億美元成長到2026年的217.3億美元，複合年成長率為6.9%。過去幾年的成長可歸因於多種因素，例如慢性疼痛疾病盛行率的上升、糖尿病發生率的增加、腫瘤治療程序的擴展、植入式幫浦技術的進步以及專業臨床照護的擴展。

預計未來幾年植入式輸液幫浦市場將維持強勁成長，2030年市場規模將達282.5億美元，複合年成長率（CAGR）為6.8%。預測期內的成長要素包括智慧輸液技術的日益普及、遠端患者監護需求的成長、個人化給藥方案的推廣、數位療法投資的增加以及植入式輸液幫浦在居家醫療環境中的廣泛應用。預測期內的主要趨勢包括可程式設計輸液幫浦的日益普及、長期疼痛管理解決方案需求的成長、智慧連網輸液幫浦的廣泛應用、植入式胰島素輸注系統的成長以及對給藥精準度的日益重視。

預計未來幾年，人口老化將推動植入式輸液幫浦市場的成長。人口老化指的是65歲以上人口占18至64歲就業人口的比例。人口老化的主要原因是醫療保健和生活水準的提高，使得預期壽命延長，導致更多人壽命延長。植入式輸液幫浦廣泛用於治療慢性疾病，而高齡化社會意味著更廣泛的潛在患者群體可以從這些設備中受益。例如，根據歐盟統計局（位於盧森堡）2025年2月發布的數據，預計到2024年歐盟人口將達到約4.49億，其中超過五分之一（21.6%）的人口年齡將在65歲及以上。歐盟人口年齡中位數為44.7歲，老年人口扶養比從2023年的33.4%上升到2024年的33.9%，增加了0.5個百分點。因此，人口老化加劇正在推動植入式輸液幫浦市場的成長。

植入式輸注泵市場的主要企業正致力於開發新產品，例如胰島素泵，以拓展客戶群、擴大銷售並增加收入。胰島素幫浦是一種旨在幫助糖尿病患者控制血糖值的醫療設備。 2023年4月，總部位於愛爾蘭的醫療設備製造商Medtronic宣布其MiniMed 780G系統獲得美國食品藥物管理局（FDA）核准，該系統配備了餐後檢測技術。該產品是目前市面上所有全自動胰島素幫浦中血糖目標值最低的（可設定低至100 mg/dL），旨在使血糖值接近非糖尿病族群的平均水平。該系統基於目標達成策略，可自動調節和校正基礎胰島素，以達到特定目標。此外，它也是唯一一款輸注裝置可舒適地配戴長達七天的胰島素幫浦。這種長期耐用性是透過先進的材料實現的，這些材料最大限度地減少了胰島素防腐劑的損失，從而保持了穩定的胰島素流量和穩定性，同時降低了輸液裝置堵塞的可能性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球植入式輸液幫浦市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 可程式輸液幫浦的廣泛應用
    • 對長期疼痛管理解決方案的需求日益成長
    • 智慧互聯幫浦的日益普及
    • 植入式胰島素輸送系統的發展
    • 更加重視劑量準確性

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心
  • 專科診所
  • 疼痛管理中心
  • 糖尿病護理中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球植入式輸液幫浦市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球植入式輸液幫浦市場規模、比較及成長率分析
  • 全球植入式輸液幫浦市場表現：規模與成長，2020-2025年
  • 全球植入式輸液幫浦市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 患者自控式止痛（PCA）幫浦、腸道餵食幫浦、胰島素幫浦、彈性幫浦、注射式幫浦及其他類型
  • 透過使用
  • 腫瘤學、小兒科或新生兒科、胃腸病學、血液學、糖尿病及其他應用
  • 最終用戶
  • 醫院、門診手術中心及專科診所
  • 按類型細分：患者自控鎮痛（PCA）泵
  • 氫可酮PCA幫浦、FentanylPCA幫浦和其他鴉片類藥物PCA泵
  • 按類型細分：腸內泵
  • 管飼泵、注射式腸道餵食幫浦、連續或間歇營養泵
  • 按類型細分：胰島素泵
  • 胰島素輸注幫浦、胰島素貼片幫浦、智慧胰島素泵
  • 按類型細分：彈性體泵
  • 一次性彈性體泵，可重複使用彈性體泵
  • 按類型細分：注射式幫浦
  • 小容量注射式幫浦，大容量注射式幫浦
  • 按類型細分：其他類型
  • 化療輸注幫浦、抗生素輸注幫浦、疼痛管理幫浦

第10章 區域與國家分析

  • 全球植入式輸液幫浦市場：區域分析、預測與趨勢（2020-2025年、2025-2030年預測、2035年預測）
  • 全球植入式輸液幫浦市場：國家/地區、績效及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 植入式輸液幫浦市場：競爭格局及市場佔有率（2024年）
  • 植入式輸液幫浦市場：公司估值矩陣
  • 植入式輸液幫浦市場：公司概況
    • Medtronic plc
    • Boston Scientific Corporation
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Fresenius Kabi AG

第37章：其他領先和創新企業

  • Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company（BD）, Roche Diagnostics International AG, Abbott Laboratories, Hospira

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年植入式輸液幫浦市場：提供新機會的國家
  • 2030年植入式輸液幫浦市場：充滿新機會的細分市場
  • 2030年植入式輸液幫浦市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MIIPN01_G26Q1

Implantable infusion pumps are advanced drug delivery systems designed to be surgically implanted within a patient's body. These devices are responsible for controlled and precise administration of medication directly into the bloodstream.

The implantable infusion pumps market is categorized into several types, including patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and other variations. For instance, insulin pumps are small devices implanted under the skin during surgical procedures to continuously deliver insulin for patients with diabetes. These implantable infusion pumps find applications across various medical fields, including oncology, pediatrics/neonatology, gastroenterology, hematology, diabetes, and more. They are commonly used in healthcare settings such as hospitals, ambulatory surgical centers, and specialty clinics to provide effective and precise drug delivery to patients.

Tariffs are impacting the implantable infusion pumps market by increasing costs of imported electronic modules, sensors, battery components, and precision pump mechanisms. Hospitals and specialty clinics in North America and Europe are most affected due to dependence on imported high-value medical components, while Asia-Pacific faces cost pressures on device exports. These tariffs are increasing device acquisition costs and slowing replacement cycles. However, they are also supporting domestic assembly, regional component sourcing, and innovation in cost-optimized implantable pump systems.

The implantable infusion pumps market research report is one of a series of new reports from The Business Research Company that provides implantable infusion pumps market statistics, including implantable infusion pumps industry global market size, regional shares, competitors with a implantable infusion pumps market share, detailed implantable infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the implantable infusion pumps industry. This implantable infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable infusion pumps market size has grown strongly in recent years. It will grow from $20.32 billion in 2025 to $21.73 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing prevalence of chronic pain conditions, rising incidence of diabetes, growth in oncology treatment procedures, advancements in implantable pump technology, expansion of specialty clinical care.

The implantable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $28.25 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing adoption of smart infusion technologies, rising demand for remote patient monitoring, expansion of personalized dosing regimens, growing investments in digital therapeutics, increasing use of implantable pumps in homecare settings. Major trends in the forecast period include increasing adoption of programmable infusion pumps, rising demand for long-term pain management solutions, growing use of smart and connected pumps, expansion of implantable insulin delivery systems, enhanced focus on dose accuracy.

The growing aging population is expected to drive the growth of the implantable infusion pumps market in the coming years. The aging population refers to the percentage of individuals aged 65 and older compared to those between 18 and 64 who are employed. The rise in the aging population is primarily due to increased life expectancy, thanks to advances in healthcare and living standards, leading to more people living longer. Implantable infusion pumps are commonly used to manage chronic conditions, which means a larger aging population translates to a greater pool of potential patients who could benefit from these devices. For example, in February 2025, Eurostat, the Luxembourg-based statistical office of the European Union, reported that the EU had an estimated population of around 449 million people in 2024, with over one-fifth (21.6%) of the population aged 65 or older. The median age of the EU population was 44.7 years, and the old-age dependency ratio in the EU increased by 0.5 percentage points between 2023 and 2024, rising from 33.4% to 33.9%. As a result, the increase in the aging population is contributing to the growth of the implantable infusion pumps market.

Leading companies in the implantable infusion pump market are focusing on the development of new products, such as insulin pumps, to address a broader customer base, boost sales, and increase revenue. Insulin pumps are medical devices designed to assist individuals with diabetes in managing their blood sugar levels. Notably, in April 2023, Medtronic, an Ireland-based medical device company, announced the FDA approval for the MiniMed 780G System featuring meal detection technology. This product distinguishes itself by setting the lowest glucose target (as low as 100 mg/dL) among all automated insulin pumps available in the market, aiming to closely mirror the average glucose levels of individuals without diabetes. The system operates on a treat-to-target basis, automatically making basal insulin adjustments and autocorrections to attain a specific target. Additionally, it stands out as the only pump featuring an infusion set that can be worn comfortably for an extended period of up to 7 days. This extended wear time is facilitated by advanced materials that minimize insulin preservative loss, maintaining consistent insulin flow and stability while reducing the likelihood of infusion set occlusion.

In May 2025, Boston Scientific, a US-based medical device company, acquired Intera Oncology, Inc. for approximately $172 million. Through this acquisition, Boston Scientific gains Intera Oncology's specialized Intera 3000 Hepatic Artery Infusion Pump and its associated floxuridine drug. This integration enhances Boston Scientific's interventional oncology portfolio by adding a proven, targeted Hepatic Artery Infusion (HAI) therapy system for treating liver tumors. Intera Oncology, Inc., a US-based company, specializes in implantable infusion pumps and chemotherapy drug delivery systems and has a strong track record in hepatic artery infusion therapy.

Major companies operating in the implantable infusion pumps market are Medtronic plc, Boston Scientific Corporation, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.

North America was the largest region in the implantable infusion pumps market in 2025. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable infusion pumps market consists of sales of instruments such as patient-controlled analgesia (PCA) pumps, enteral pumps, insulin pumps, elastomeric pumps, syringe pumps, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Infusion Pumps Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses implantable infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable infusion pumps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable infusion pumps market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Patient-Controlled Analgesia (PCA) Pumps; Enteral Pumps; Insulin Pumps; Elastomeric Pumps; Syringe Pumps; Other Types
  • 2) By Applications: Oncology; Pediatrics Or Neonatology; Gastroenterology; Hematology; Diabetes; Other Applications
  • 3) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
  • Subsegments:
  • 1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps; Fentanyl PCA Pumps; Other Opioid PCA Pumps
  • 2) By Enteral Pumps: Tube Feeding Pumps; Syringe-based Enteral Pumps; Continuous Or Intermittent Feeding Pumps
  • 3) By Insulin Pumps: Insulin Delivery Pumps; Insulin Patch Pumps; Smart Insulin Pumps
  • 4) By Elastomeric Pumps: Disposable Elastomeric Pumps; Reusable Elastomeric Pumps
  • 5) By Syringe Pumps: Small Volume Syringe Pumps; Large Volume Syringe Pumps
  • 6) By Other Types: Chemotherapy Infusion Pumps; Antibiotic Infusion Pumps; Pain Management Pumps
  • Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Baxter International Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Smiths Medical a Smiths Group company; Terumo Corporation; Johnson & Johnson; Greatbatch Medical; Primetech Corporation; Flowonix Medical Inc.; F. Hoffmann-La Roche Ltd; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Micrel Medical; Insulet Corporation; ICU Medical Inc.; Becton Dickinson and Company (BD); Roche Diagnostics International AG; Abbott Laboratories; Hospira; Teleflex Incorporated; C. R. Bard Inc.; AngioDynamics Inc.; Merit Medical Systems Inc.; NIPRO Medical Corporation; IRadimed Corporation; Zyno Medical; Tricumed Medizintechnik GmbH; Q Core Medical Ltd.; Ivenix Inc.; Tandem Diabetes Care Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Implantable Infusion Pumps Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Implantable Infusion Pumps Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Implantable Infusion Pumps Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Implantable Infusion Pumps Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Programmable Infusion Pumps
    • 4.2.2 Rising Demand For Long-Term Pain Management Solutions
    • 4.2.3 Growing Use Of Smart And Connected Pumps
    • 4.2.4 Expansion Of Implantable Insulin Delivery Systems
    • 4.2.5 Enhanced Focus On Dose Accuracy

5. Implantable Infusion Pumps Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Specialty Clinics
  • 5.4 Pain Management Centers
  • 5.5 Diabetes Care Centers

6. Implantable Infusion Pumps Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Implantable Infusion Pumps Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Implantable Infusion Pumps PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Implantable Infusion Pumps Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Implantable Infusion Pumps Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Implantable Infusion Pumps Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Implantable Infusion Pumps Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Implantable Infusion Pumps Market Segmentation

  • 9.1. Global Implantable Infusion Pumps Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, Other Types
  • 9.2. Global Implantable Infusion Pumps Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology, Pediatrics Or Neonatology, Gastroenterology, Hematology, Diabetes, Other Applications
  • 9.3. Global Implantable Infusion Pumps Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Specialty Clinics
  • 9.4. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Morphine PCA Pumps, Fentanyl PCA Pumps, Other Opioid PCA Pumps
  • 9.5. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Enteral Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tube Feeding Pumps, Syringe-based Enteral Pumps, Continuous Or Intermittent Feeding Pumps
  • 9.6. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Delivery Pumps, Insulin Patch Pumps, Smart Insulin Pumps
  • 9.7. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Elastomeric Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Elastomeric Pumps, Reusable Elastomeric Pumps
  • 9.8. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Syringe Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Small Volume Syringe Pumps, Large Volume Syringe Pumps
  • 9.9. Global Implantable Infusion Pumps Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Chemotherapy Infusion Pumps, Antibiotic Infusion Pumps, Pain Management Pumps

10. Implantable Infusion Pumps Market Regional And Country Analysis

  • 10.1. Global Implantable Infusion Pumps Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Implantable Infusion Pumps Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Implantable Infusion Pumps Market

  • 11.1. Asia-Pacific Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Implantable Infusion Pumps Market

  • 12.1. China Implantable Infusion Pumps Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Implantable Infusion Pumps Market

  • 13.1. India Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Implantable Infusion Pumps Market

  • 14.1. Japan Implantable Infusion Pumps Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Implantable Infusion Pumps Market

  • 15.1. Australia Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Implantable Infusion Pumps Market

  • 16.1. Indonesia Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Implantable Infusion Pumps Market

  • 17.1. South Korea Implantable Infusion Pumps Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Implantable Infusion Pumps Market

  • 18.1. Taiwan Implantable Infusion Pumps Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Implantable Infusion Pumps Market

  • 19.1. South East Asia Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Implantable Infusion Pumps Market

  • 20.1. Western Europe Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Implantable Infusion Pumps Market

  • 21.1. UK Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Implantable Infusion Pumps Market

  • 22.1. Germany Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Implantable Infusion Pumps Market

  • 23.1. France Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Implantable Infusion Pumps Market

  • 24.1. Italy Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Implantable Infusion Pumps Market

  • 25.1. Spain Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Implantable Infusion Pumps Market

  • 26.1. Eastern Europe Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Implantable Infusion Pumps Market

  • 27.1. Russia Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Implantable Infusion Pumps Market

  • 28.1. North America Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Implantable Infusion Pumps Market

  • 29.1. USA Implantable Infusion Pumps Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Implantable Infusion Pumps Market

  • 30.1. Canada Implantable Infusion Pumps Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Implantable Infusion Pumps Market

  • 31.1. South America Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Implantable Infusion Pumps Market

  • 32.1. Brazil Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Implantable Infusion Pumps Market

  • 33.1. Middle East Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Implantable Infusion Pumps Market

  • 34.1. Africa Implantable Infusion Pumps Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Implantable Infusion Pumps Market, Segmentation By Type, Segmentation By Applications, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Implantable Infusion Pumps Market Regulatory and Investment Landscape

36. Implantable Infusion Pumps Market Competitive Landscape And Company Profiles

  • 36.1. Implantable Infusion Pumps Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Implantable Infusion Pumps Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Implantable Infusion Pumps Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

37. Implantable Infusion Pumps Market Other Major And Innovative Companies

  • Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira

38. Global Implantable Infusion Pumps Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Implantable Infusion Pumps Market

40. Implantable Infusion Pumps Market High Potential Countries, Segments and Strategies

  • 40.1 Implantable Infusion Pumps Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Implantable Infusion Pumps Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Implantable Infusion Pumps Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer